Pathstone Holdings »

Acumen Pharmaceuticals shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.8M 479k 3.84

More positions owned by Pathstone Holdings

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Crowdstrike Hldgs Cl A (CRWD)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Rus 1000 Etf (IWB)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds Large Cap Etf (VV)
Coca-Cola Company (KO)
Amazon (AMZN)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Pathstone Holdings

Top funds holding Acumen Pharmaceuticals

RA Capital Management
Franklin Resources
Laurion Capital Management
Vanguard Group
Millennium Management
Alyeska Investment Group
Jane Street
Hudson Bay Capital Management
Schonfeld Strategic Advisors
Pathstone Holdings
Ikarian Capital
Tang Capital Management
Two Sigma Investments
Citigroup
Man Group

View all funds holding Acumen Pharmaceuticals